Search Results

There are 30975 results for: content related to: Commentary: physical activity and NAFLD - cause or effect? Authors' reply

  1. You have free access to this content
    Meta-analysis: vitamin D and non-alcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 3, August 2013, Pages: 246–254, M. Eliades, E. Spyrou, N. Agrawal, M. Lazo, F. L. Brancati, J. J. Potter, A. A. Koteish, J. M. Clark, E. Guallar and R. Hernaez

    Version of Record online : 20 JUN 2013, DOI: 10.1111/apt.12377

  2. You have free access to this content
    Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 9, November 2015, Pages: 1051–1063, A. Wieland, D. N. Frank, B. Harnke and K. Bambha

    Version of Record online : 24 AUG 2015, DOI: 10.1111/apt.13376

  3. You have free access to this content
    Review article: the management of paediatric nonalcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 10, November 2014, Pages: 1155–1170, E. B. Mitchel and J. E. Lavine

    Version of Record online : 29 SEP 2014, DOI: 10.1111/apt.12972

  4. You have free access to this content
    PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 5, March 2014, Pages: 532–539, J. Shen, G. L.-H. Wong, H. L.-Y. Chan, H.-Y. Chan, D. K.-W. Yeung, R. S.-M. Chan, A. M.-L. Chim, A. W.-H. Chan, P. C.-L. Choi, J. Woo, W. C.-W. Chu and V. W.-S. Wong

    Version of Record online : 13 JAN 2014, DOI: 10.1111/apt.12609

  5. You have free access to this content
    Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 9, November 2013, Pages: 1038–1044, A. Yesil and Y. Yilmaz

    Version of Record online : 11 SEP 2013, DOI: 10.1111/apt.12489

  6. Magnetic resonance elastography identifies fibrosis in adults with alpha-1 antitrypsin deficiency liver disease: a prospective study

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 3, August 2016, Pages: 287–299, R. G. Kim, P. Nguyen, R. Bettencourt, P. S. Dulai, W. Haufe, J. Hooker, J. Minocha, M. A. Valasek, H. Aryafar, D. A. Brenner, C. B. Sirlin and R. Loomba

    Version of Record online : 9 JUN 2016, DOI: 10.1111/apt.13691

  7. You have free access to this content
    Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 10, November 2014, Pages: 1209–1222, L. Fedchuk, F. Nascimbeni, R. Pais, F. Charlotte, C. Housset, V. Ratziu and forthe LIDO Study Group

    Version of Record online : 29 SEP 2014, DOI: 10.1111/apt.12963

  8. You have free access to this content
    Review article: the diagnosis of non-alcoholic fatty liver disease – availability and accuracy of non-invasive methods

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 4, February 2013, Pages: 392–400, D. Festi, R. Schiumerini, L. Marzi, A. R. Di Biase, D. Mandolesi, L. Montrone, E. Scaioli, G. Bonato, G. Marchesini-Reggiani and A. Colecchia

    Version of Record online : 20 DEC 2012, DOI: 10.1111/apt.12186

  9. You have free access to this content
    Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 1, January 2016, Pages: 83–95, I. Doycheva, J. Cui, P. Nguyen, E. A. Costa, J. Hooker, H. Hofflich, R. Bettencourt, S. Brouha, C. B. Sirlin and R. Loomba

    Version of Record online : 15 SEP 2015, DOI: 10.1111/apt.13405

  10. You have free access to this content
    Association between aspirin use and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 9, November 2014, Pages: 1066–1073, H. Shen, G. Shahzad, M. Jawairia, R. M. Bostick and P. Mustacchia

    Version of Record online : 1 SEP 2014, DOI: 10.1111/apt.12944

  11. You have free access to this content
    Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey

    Alimentary Pharmacology & Therapeutics

    R. J. Wong, B. Liu and T. Bhuket

    Version of Record online : 15 SEP 2017, DOI: 10.1111/apt.14327

  12. Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population

    Alimentary Pharmacology & Therapeutics

    Volume 46, Issue 4, August 2017, Pages: 447–456, T. C.-F. Yip, A. J. Ma, V. W.-S. Wong, Y.-K. Tse, H. L.-Y. Chan, P.-C. Yuen and G. L.-H. Wong

    Version of Record online : 6 JUN 2017, DOI: 10.1111/apt.14172

  13. You have full text access to this OnlineOpen article
    Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 8, October 2016, Pages: 877–889, M. Munteanu, D. Tiniakos, Q. Anstee, F. Charlotte, G. Marchesini, E. Bugianesi, M. Trauner, M. Romero Gomez, C. Oliveira, C. Day, J.-F. Dufour, S. Bellentani, Y. Ngo, S. Traussnig, H. Perazzo, O. Deckmyn, P. Bedossa, V. Ratziu, T. Poynard and the FLIP Consortium and the FibroFrance Group

    Version of Record online : 23 AUG 2016, DOI: 10.1111/apt.13770

  14. You have free access to this content
    Non-alcoholic fatty liver diseases and risk of colorectal neoplasia

    Alimentary Pharmacology & Therapeutics

    Volume 45, Issue 2, January 2017, Pages: 345–353, J. S. Ahn, D. H. Sinn, Y. W. Min, S. N. Hong, H. S. Kim, S.-H. Jung, S. Gu, P.-L. Rhee, S. W. Paik, H. J. Son and G.-Y. Gwak

    Version of Record online : 18 NOV 2016, DOI: 10.1111/apt.13866

  15. You have free access to this content
    Review article: fructose in non-alcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 10, May 2012, Pages: 1135–1144, Y. Yilmaz

    Version of Record online : 2 APR 2012, DOI: 10.1111/j.1365-2036.2012.05080.x

  16. You have free access to this content
    I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 5, March 2016, Pages: 631–642, M.-F. Xia, Y. Ling, H. Bian, H.-D. Lin, H.-M. Yan, X.-X. Chang, X.-M. Li, H. Ma, D. Wang, L.-S. Zhang, S.-S. Wang, B.-J. Wu, W.-Y. He, N.-Q. Zhao and X. Gao

    Version of Record online : 13 JAN 2016, DOI: 10.1111/apt.13521

  17. You have free access to this content
    Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 6, September 2015, Pages: 731–740, V. W.-S. Wong, G. L.-H. Wong, H.-Y. Chan, D. K.-W. Yeung, R. S.-M. Chan, A. M.-L. Chim, C. K.-M. Chan, Y.-K. Tse, J. Woo, W. C.-W. Chu and H. L.-Y. Chan

    Version of Record online : 23 JUL 2015, DOI: 10.1111/apt.13327

  18. You have free access to this content
    Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 8, October 2012, Pages: 772–781, L. Gerber, M. Otgonsuren, A. Mishra, C. Escheik, A. Birerdinc, M. Stepanova and Z. M. Younossi

    Version of Record online : 8 SEP 2012, DOI: 10.1111/apt.12038

  19. Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 45, Issue 11, June 2017, Pages: 1403–1412, J. J. Kim, D. Kim, J. Y. Yim, J. H. Kang, K. H. Han, S. M. Kim, K. R. Hwang, S. Y. Ku, C. S. Suh, S. H. Kim and Y. M. Choi

    Version of Record online : 30 MAR 2017, DOI: 10.1111/apt.14058

  20. You have free access to this content
    Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 5, September 2015, Pages: 582–590, E. C. Verna, J. Patel, R. Bettencourt, P. Nguyen, C. Hernandez, M. A. Valasek, T. Kisselva, D. A. Brenner and R. Loomba

    Version of Record online : 29 JUN 2015, DOI: 10.1111/apt.13292